TELL ME MORE ABOUT THIS STUDY
This is a safety and efficacy study for Adults with Severe or Very Severe Alopecia Areata
Enrolling Adults (Male: 18-60) or (Female: 18-70) in Owensboro, Kentucky
This study is for patients with severe or very severe Alopecia. Our study team will help determine if you qualify by asking about your recent diagnosis and discussing your medical history. Space is limited…contact us today!
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ACNE A Study comparing the Efficacy and Safety of Active Gel to Placebo in Treatment of Acne Vulgaris | Evansville | Recruiting | 9+ | $300 | Request Info | |
| ADHD Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (blind and open label extension) | Owensboro | Closed to Enrollment | 6 - 12 | $450/$850 | Request Info | |
| ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 60 (Males) 18 - 70 (Females) | $950 | Request Info | |
| ANKYLOSING SPONDYLITIS (AS) Open label efficacy study comparing dosing strategies of a subcutaneous injectable biologic in patients with AS and accompanying back pain | Evansville | Recruiting | 18+ | $950 | Request Info | |
| ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $800 | Request Info | |
| ECZEMA (Atopic Dermatitis) Dose ranging, placebo-controlled study in patients with moderate to severe atopic dermatitis | Evansville | Recruiting | 18+ | $75 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled with open-label extension study in patients with moderate to severe atopic dermatitis | Owensboro | Recruiting | 18+ | $550 - $1200 | Request Info | |
| HIDRADENITIS SUPPURATIVA (HS) Safety and efficacy, placebo-controlled study with re-randomization in patients with moderate to severe HS (Hurley Stage II and III) | Evansville | Recruiting | 18+ | $1075 | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| INFANT FORMULA Comparison Study | Evansville | Recruiting | Newborns | Variable up to $150 plus supply of formula and diapers | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Recruiting | 18 - 65 | $750 | Request Info | |
| MOLLUSCUM CONTAGIONSUM An Open Label PK Study Assessing Safety, Tolerability, and PK of Topical Treatment of Molluscum Contagiosum | Owensboro Evansville | Closed to enrollment | 6 months - Adult | $1200 | Request Info | |
| PSORIASIS Dose Ranging, Safety and Efficacy, 16 week placebo-controlled with open-label follow-up study in patients with moderate to severe plaque psoriasis. | Owensboro | Closed to enrollment | 18-75 | $1050 | Request Info | |
| PSORIASIS A Vehicle Controlled Study, w/ Open Lable Extension to evaluate the Efficacy and Safety of 1% TOPICAL cream in treatment of mild to moderate plaque psoriasis | Owensboro Evansville | Recruiting | 18-75 | Up to $950 | Request Info | |
| RHEUMATOID ARTHRITIS (RA) Comparison Study between three biologics used to treat RA - Long Term Treatment | Evansville | Closed to Enrollment | 18+ | $375 during year 1 + $75 per simi-annual visit thereafter | Request Info | |